Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Soldan

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Sexually Transmitted Infections|June 8, 2026
From silos to synergies: harnessing the power of sexual health data sources in England to understand changing epidemiology and inform policyDana Ogaz, Anika Knuppel, Emily Trickett, et al.
Sexually Transmitted Infections|January 21, 2012
Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in BritainAnne M Johnson, Catherine H Mercer, Simon Beddows, et al.
Sexually Transmitted Infections|September 5, 2020
Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional studySarah Kerry-Barnard, Simon Beddows, Fiona Reid, et al.
Plos One|April 25, 2019
Correction: Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infectionsPaula B Blomquist, Stephanie J Migchelsen, Gillian Wills, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 28, 2019
Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017Michael Edelstein, Nalini Iyanger, Nicola Hennessy, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
Plos One|December 18, 2018
Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infectionsPaula B Blomquist, Stephanie J Mighelsen, Gillian Wills, et al.
Clinical and Vaccine Immunology : CVI|January 27, 2012
Human papillomavirus antibody reference reagents for use in postvaccination surveillance serologySara L Bissett, Dianna Wilkinson, Kate I Tettmar, et al.
Journal of Medical Virology|August 13, 2011
Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and malesSara L Bissett, Rebecca Howell-Jones, Craig Swift, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Sexually Transmitted Infections|June 8, 2026
From silos to synergies: harnessing the power of sexual health data sources in England to understand changing epidemiology and inform policyDana Ogaz, Anika Knuppel, Emily Trickett, et al.
Sexually Transmitted Infections|January 21, 2012
Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in BritainAnne M Johnson, Catherine H Mercer, Simon Beddows, et al.
Sexually Transmitted Infections|September 5, 2020
Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional studySarah Kerry-Barnard, Simon Beddows, Fiona Reid, et al.
Plos One|April 25, 2019
Correction: Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infectionsPaula B Blomquist, Stephanie J Migchelsen, Gillian Wills, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|February 28, 2019
Implementation and evaluation of the human papillomavirus (HPV) vaccination pilot for men who have sex with men (MSM), England, April 2016 to March 2017Michael Edelstein, Nalini Iyanger, Nicola Hennessy, et al.
BMC Medical Research Methodology|November 8, 2018
Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)Macey L Murray, Jade Meadows, Caroline J Doré, et al.
Plos One|December 18, 2018
Sera selected from national STI surveillance system shows Chlamydia trachomatis PgP3 antibody correlates with time since infection and number of previous infectionsPaula B Blomquist, Stephanie J Mighelsen, Gillian Wills, et al.
Clinical and Vaccine Immunology : CVI|January 27, 2012
Human papillomavirus antibody reference reagents for use in postvaccination surveillance serologySara L Bissett, Dianna Wilkinson, Kate I Tettmar, et al.
Journal of Medical Virology|August 13, 2011
Human papillomavirus genotype detection and viral load in paired genital and urine samples from both females and malesSara L Bissett, Rebecca Howell-Jones, Craig Swift, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 25, 2016
Impact and Cost-effectiveness of Selective Human Papillomavirus Vaccination of Men Who Have Sex With MenAllen Lin, Koh J Ong, Peter Hobbelen, et al.
Pageof 7